Although tobacco has been clearly implicated as a cause of a number of cancers, earlier studies had not generally found cigarette smokers to be at higher risk for cancers of the large bowel. Unlike the earlier studies, more recent studies have tended to find cigarette smokers to be at higher risk of colorectal cancer. In addition, cigarette smoking has been consistently associated with a higher risk of colorectal adenomas, precursors of cancers. We hypothesize that smoking is an initiator of colorectal carcinogenesis. The consistent finding of a positive association between smoking and risk of adenomas may reflect the presumably shorter induction period for these lesions. Recent studies indicate that an increased risk for large-bowel cancer emerges only after about four decades after one begins smoking, perhaps accounting for the null studies that were conducted earlier during the smoking epidemic. Most studies had not taken into account an induction period between timing of smoking and risk for cancer Colorectal cancer is the second leading cause of cancer mortality in the United States, accounting for about 56 000 deaths annually (/). A genetic component is now well established (2), but evidence, based in part on differences in cancer rates among countries (3,4) and changes in rates over time (5) and among migrants (6), points to the importance of alterable factors. Second only to lung cancer, the high mortality rate of this cancer has prompted considerable research into its cause, particularly as related to dietary factors. Tobacco use is known to cause many types of cancers, including those in organs not in direct contact with smoke. However, evidence of a role for tobacco in the cause of colorectal cancer has been inconclusive, although a higher risk for adenomatous polyps, colorectal cancer precursors (7, 8) , has been observed consistently in smokers.
Colorectal cancer is the second leading cause of cancer mortality in the United States, accounting for about 56 000 deaths annually (/) . A genetic component is now well established (2), but evidence, based in part on differences in cancer rates among countries (3, 4) and changes in rates over time (5) and among migrants (6) , points to the importance of alterable factors. Second only to lung cancer, the high mortality rate of this cancer has prompted considerable research into its cause, particularly as related to dietary factors. Tobacco use is known to cause many types of cancers, including those in organs not in direct contact with smoke. However, evidence of a role for tobacco in the cause of colorectal cancer has been inconclusive, although a higher risk for adenomatous polyps, colorectal cancer precursors (7, 8) , has been observed consistently in smokers.
The apparent discrepancy between the results of studies of adenomas and those of cancers is puzzling and requires a resolution. Several possible explanations exist. The positive association between tobacco and colorectal adenoma may not be causal and perhaps reflects an unidentified methodologic bias, or smoking may contribute to cause a subgroup of adenomas that do not possess the potential to develop further into cancers. Alternatively, smoking may act only during the early stages of carcinogenesis, and an association with cancers may have been missed because the elevated risk of colorectal cancer occurs many years after the time of smoking. Another explanation may be that smoking increases the initiation rate of colorectal cancer but additionally may act as an antipromotor at later stages; the two opposing effects tend to cancel out.
Because of the unresolved issues regarding smoking and risk of colorectal cancer, we evaluated the available evidence for the role of tobacco in the causation of cancers and adenomas of the large bowel. We searched the MEDLINE and CANCERLIT databases through May 1996 and cross-checked the references in all articles in an attempt to obtain all pertinent publications on smoking and risk of colorectal cancer and adenoma. To examine the influence of smoking at various phases throughout the natural history of colorectal carcinogenesis, we used the diagnosis of small adenomas, large adenomas, and cancers to represent progressive stages of the natural history of colon cancer. We also considered the impact of smoking on population rates of colorectal cancer, including sex differences, and individual susceptibility on the basis of polymorphisms in xenobiotic metabolizing enzymes. The potential clinical, public health, and research implications are also discussed.
Natural History of Colorectal Cancer
Carcinogenesis can be divided into an irreversible "initiation" phase, arising primarily from damage to DNA by covalent binding of carcinogens, and a "promotional" phase, during which initiated cells are converted to the malignant phenotype (9) . Generally, initiators and promotors tend to be distinct factors. Because they are precursors for most colorectal cancers (8) , colorectal adenomas, particularly those classified as small (<1 cm), may be used to examine factors that operate early in carcinogenesis, such as initiators. Increases in adenoma size are associated with increases in dysplasia, genetic aberrations, and malignant potential (8) . Large adenomas and cancers would tend to reflect recent promoting factors and initiating factors from the more distant past.
Three empiric stages can be defined for colorectal carcinogenesis: adenoma formation, adenoma growth, and malignant transformation. Several observations indicate that a substantial number of years, at least several decades, is generally required for completion of all three stages. Even though a small adenoma will appear closest in time to initiation, an unknown period of time is also required for a small adenoma to develop following the initiating event. Once an adenoma is formed, appreciable growth may occur only after many years. One study (10) estimated that, on average, a 1-mm adenoma will grow to 1 cm in about 10 years and to 2 cm in about 15 years. Even when the large adenoma stage is reached, several more decades may be required for carcinogenic transformation. For example, among 226 patients with large, untreated adenomas, the calculated risk of colon cancer at the index polyp site was 2.5% at 5 years, 8% at 10 years, and 24% at 20 years (//). These estimates represent an underestimate of the time to cancer, since the index large adenomas had been present for an unknown length of time prior to diagnosis. Finally, even after transformation occurs, a latency period of several years could be present before the tumor is diagnosed.
Indirect evidence also supporting the requirement of several decades for colorectal cancer development following the initiating event is based on the time course for events in familial adenomatous polyposis (FAP), a syndrome that invariably leads to colorectal cancer among the untreated. Although FAP is a rare heritable disease, mutations in the same gene, the adenomatous polyposis coli (APC) gene, are now known to underlie both FAP cancers and most sporadic colorectal adenocarcinomas (12) . A rumor diagnosed in a patient with FAP was "initiated" at the beginning of life by a germline mutation in the APC gene, whereas a non-FAP or sporadic tumor was initiated by a somatic APC mutation at some point after birth. Generally, untreated individuals with FAP usually develop numerous small adenomas in their childhood, some of which acquire further genetic aberrations associated with adenoma growth. Large adenomas are typically diagnosed when patients with FAP reach their twenties (13, 14) . Although these individuals have a germline mutation of the APC gene at birth, the average age of developing a large-bowel cancer is about 40 years. Thus, if nonhereditary colorectal cancers, once initiated with an APC mutation, have a similar natural history as FAP-related cancers, an appreciable rise in the colorectal cancer rate is predicted only after about four decades following the genetic insult.
Because numerous carcinogens or genotoxic agents from tobacco can reach the large bowel via the circulatory system, tobacco could plausibly initiate colorectal cancer. Smoking acts as a cancer promotor in sites that experience direct contact with smoke, but whether a promotional role for tobacco would occur at distant sites is unclear. On the basis of the time sequence for events in colorectal carcinogenesis, if tobacco-related carcinogens initiate colorectal cancer, one might predict a narrower interval between the time of smoking and the risk of adenoma than for cancer, for which an association may be detected only several decades after the time of smoking.
Cigarette Smoking and Colorectal Adenomas
Cigarette smoking has been associated with risk of colorectal adenomas in men and women (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) with remarkable consistency. Studies almost invariably have found a twofold to threefold higher risk associated with long-term smoking, generally 20-40 pack-years of cigarettes (Table 1) . Studies have often found positive associations with current and past smoking, but a dose-response relationship with pack-years of smoking has been the most consistent association. Two case-control studies found no association between cigarette smoking and adenoma risk. One of these studies (30) was conducted in the United States and suggested a nonsignificant increase in women but not men. The second study (31) was based on only 86 cases in Japan. Interestingly, an analysis of 116 additional cases, which occurred in the next 2 years of follow-up in the same population, yielded a positive association (21) . One small study (32) , based on 79 cases of polyp prevalence at autopsy among Hawaiian-Japanese men, found only a small nonsignificant excess of ever smokers (assessed in 1965-1968) among polyp bearers relative to subjects without polyps.
Only two published studies have addressed the influence of cigarette smoking on the recurrence rate of colorectal adenomas, i.e., the recurrence of new adenomas among those patients previously diagnosed with adenomas. In one study (55) , on the basis of only 23 cases of hyperplastic and adenomatous polyps combined, no appreciable relationship was noted, although current male smokers were at slightly higher risk of polyp recurrence. However, besides being based on very small numbers, this study did not distinguish adenomatous from hyperplastic polyps and thus provides limited information. In the second study (34) , comprising 186 recurrent polyp cases and 330 individuals with no adenomas at follow-up, the risk of recurrent adenomas was higher among smokers than never smokers among both males and females. Similar to studies examining initial adenomas, a twofold to threefold elevation in risk of recurrent adenomas was associated with a 30-40 pack-year smoking history. The finding that a high risk of recurrence persisted after 10 years of smoking cessation suggests an initiating role for tobacco. Preliminary evidence from another study of recurrent adenomas also shows that current smoking doubled the risk of recurrent adenomas in men (P = .001) but was associated with only a 13% nonsignificant elevated risk in women (35) . *CI = confidence interval; M = male; F = female; endos = endoscoped; PY = pack-years; AP = adenomatous polyps; HP = hyperplastic polyps; FOB-= fecal ( cult blood negative, FOB+ = fecal occult blood positive.
The strength and the dose-response pattern of the association between smoking and colorectal adenoma in men and women observed consistently in numerous studies conducted within different countries, and its persistence even after controlling for confounders, including diet and alcohol, are consistent with a causal association (36). Reporting or recall bias cannot entirely explain the findings because this association has been found in studies (26, 27) that assessed smoking prior to the diagnosis of adenoma. Because studies of adenomas may be particularly prone to detection biases, we consider the potential impact of several biases, which theoretically could have spuriously produced an association between smoking and adenoma risk.
A major concern of adenoma studies is that individuals may present for endoscopy for various reasons, and possibly smokers are more likely to undergo endoscopy for indications related to an underlying polyp as compared with nonsmokers. However, studies of screening populations, where all in the defined population are screened regardless of symptoms, as well as studies of recurrent adenomas, in which all enrolled individuals are followed systematically, should not be prone to this bias. In fact, studies (21) (22) (23) 25) based on screening all individuals in a defined population indicate a higher risk of colorectal adenoma among smokers, as do studies (34, 35) of recurrent adenomas. Additionally, subanalyses in some studies (26, 27) limited to an asymptomatic screening group have also yielded positive results for smoking.
Another possibility is that adenomas may be more easily detectable by endoscopy for smokers, perhaps because of a relaxing effect of nicotine on the large bowel. However, the fact that an association is observed, even among past smokers in many studies, argues against this (19, 21, 22, 24, 26, 27, 29, 34) . Moreover, this bias appears more plausible for minute adenomas, but a relationship with tobacco has also been observed for large adenomas (18, 21, 23, (26) (27) (28) (29) .
Because colorectal adenomas are well-established precursor lesions for cancers, the absence of a similarly consistent association between smoking and colorectal cancer has been quite puzzling. As described above, biased results from adenoma studies are unlikely to have accounted for the generally positive results. Several explanations have been offered, including the suggestion that adenomas are heterogeneous with regard to their potential to progress, and smoking increases the risk only of adenomas that are not capable of further progression to cancer (37) . However, no available evidence suggests that any sub-group of adenomas is inherently incapable of progression. For example, colorectal cancers appear to be initiated by mutations in the APC gene (72) ; although the specific mutations of this gene (FAP syndrome) are quite heterogeneous (12, 38) , and presumably may have some phenotypic variability, there is no documented case of FAP that yields adenomas that do not have malignant potential. Moreover, the possibility that smoking causes only adenomas destined not to become malignant would be more plausible if smoking was only associated with risk for small adenomas. However, smoking is also associated with the risk for larger adenomas (18, 21, 23, (26) (27) (28) (29) , which have acquired additional genetic alterations often observed in cancers, indicating that tobacco-associated adenomas have the capacity for progression.
An alternative explanation for the apparent discrepancy in studies of adenomas and cancers is that smoking is an initiator, but continued smoking acts as an "antipromotor." However, no evidence supports this, and the association with large adenomas tends to argue against an antipromoting influence of smoking.
Because no obvious methodologic bias accounts for the discrepant results between studies of adenomas and cancer, we hypothesize that smoking causes an initiating event that could induce small adenomas, which with additional specific genetic abnormalities could progress to large adenomas and cancers. Possibly, an association with cancer has been missed in many studies because the interval between the time of smoking and elevated colorectal cancer risk comprises several decades. We next consider the available evidence for cigarette smoking and colorectal cancer, paying particular attention to the time relationship between smoking and risk for this disease.
Cigarette Smoking and Colorectal Cancer
On first inspection, evidence for an association between tobacco and colorectal cancer appears inconsistent. Although some epidemiologic studies (26, (39) (40) (41) (42) (43) (44) (45) (46) suggest a positive association between smoking and colorectal cancer risk in men, most have not supported this association (Tables 2 and 3 ) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) (64) (65) . Among women, the evidence is even weaker, with a null or weakly positive or inverse association comprising the typical observation (66) (67) (68) (69) , although two recent studies (27, 70) do support an association. However, if smoking acts as an initiator of carcinogenesis, it is critical to examine the time when smoking first began in relation to the risk of colorectal cancer.
The risk of colorectal adenoma and cancer in relation to the time one had begun smoking was tested in two prospective studies (26, 27) . In both studies, after allowing for the minimum induction period of 35 years, as estimated from the data, a doseresponse relationship was observed between pack-years of cigarettes smoked and colorectal cancer; more than a doubling of risk for cancer occurred among men and women who had accumulated at least 10 pack-years of cigarette smoking more than 35 years in the past relative to never smokers. In the same populations, tobacco use within the past two decades was a strong determinant of risk for small colorectal adenomas, and pack-years accumulated more than two decades in the past determined risk for large adenomas. These findings are consistent with the following: over a period of three to four decades, smoking initiates cells of the colorectum, and some of these progress to form small adenomas, of which a proportion develop into large adenomas and ultimately adenocarcinomas.
Although few epidemiologic studies found an association between smoking and colorectal cancer in women, if three to four decades separate the time when one smokes and the time of presumably higher risk for large-bowel cancer, most of the available data are uninformative because women did not smoke in large numbers until the late 1940s and 1950s (71) , and thus a discernible rise in the incidence of this cancer would not be expected until the late 1980s. Studies of smoking and colorectal cancer risk among women in the United States have been consistently null up to around 1990. Since then, two recent studies (27, 70) of women, which included cases diagnosed after 1990, have found long-term smoking associated with an increased risk of large-bowel cancer. In one of these studies (27) , a follow-up study among nurses, an earlier analysis was consistent with other studies in women, finding only a weak, nonsignificant association between smoking history and colon cancer, although past smoking was significantly associated with the risk of rectal carcinoma (72) . In this earlier report of the Nurses' Health Study, which included cases diagnosed from June 1976 through May 1984, very few women had begun smoking more than 35-40 years in the past. Fig. 1 illustrates the relative risks of colorectal cancer associated with cigarette smoking from various U.S. studies in women over time. As hypothesized, on the basis of the long induction period between the time of smoking and the risk of colorectal cancer, only in the latter half of the 1980s has a positive association emerged. The relative risks correspond quite closely with the increasing proportion of women over time who began smoking at least 40 years in the past (73) . In Fig. 1 , we do not include studies outside the United States because we are not able to ascertain the past patterns of smoking in these countries.
Because men generally started smoking earlier in the century in the United States, an association with smoking should have appeared earlier. As described previously, a cohort study of men (26) , which directly assessed induction period, found that an association with colorectal cancer emerged 35-40 years after the onset of smoking. The impact of the long induction period has also been observed indirectly in two populations of men, which initially published weak or nonexistent associations with smoking (47, 49) and subsequently found positive associations (43, 44) . The earlier follow-up periods in these studies occurred primarily in the 1950s and early 1960s, during which an association may have been missed, even in men, particularly since these analyses did not explicitly consider lengthy induction periods. With subsequent follow-up, associations emerged in these two studies. Fig. 2 illustrates the close correspondence between per capita cigarette consumption 40 years in the past and the relative risk for colorectal cancer by study period in U.S. men. Although the data do not distinguish cigarette consumption by sex (73) , smoking by males accounted for the vast majority of tobacco use up until 1935. Thus, by 1975, most of the cigarettes consumed more than 40 years in the past were by males.
In general, tobacco appears to be a risk factor for both colon and rectal cancers. Recent studies (26, 27, 43, 70) supporting an association for colorectal cancers have tended to find similar associations in the colon and rectum, and the adenoma studies have generally found associations in both the colon and rectum.
As a group, case-control studies that have used hospitalVery few available data relate to differences in the proximal and based control subjects have, for the most part, not supported an distal colon. association between tobacco use and colorectal cancer risk. •Does not include studies where only crude relative risks (RRs) were provided. tM = male; F = female; cig/day = cigarettes/day; g/day = grams of tobacco/day (I cigarette contains approximately I g of tobacco); y = years; CR = colorectal; PY = pack-years; Cl = confidence interval.
However, most of these studies (74) (75) (76) (77) (78) were conducted before 1970, and the presumed induction period of about 40 years may not yet have occurred. Two hospital-based, case-control studies that were conducted more recently [1973-1976 (79) and 1984-1986 (80,81) ] found elevated risks only among those who had smoked for more than 20 and 30 years, respectively. A small Japanese study (52) of 59 male and 34 female case patients with colorectal cancer conducted in 1981-1983 was null, but smoking became prevalent in Japan only in the 1950s, so it is unlikely that sufficient numbers of subjects had accrued 40 or more years of smoking.
We considered alternative explanations for causality in the studies supporting an association between tobacco and colorectai cancer risk. Confounding by alcohol, diet, and physical activity is possible, but recent studies (26, 27, 70) that have controlled for these have not found confounding to be appreciable. Because of their generally less health-conscious lifestyle and the possibility that smoking may mask gastrointestinal symptoms, and given that smokers tend to be diagnosed with colorectal cancer at more advanced stages than nonsmokers (83) (84) (85) , any detection bias is likely to cause an underestimation of the cancer rate in smokers. Publication bias could have produced a pattern in which many initially null studies were published, followed by the selective reporting and publishing of only positive findings deemed to be interesting. However, publication bias would not explain simply the divergent male-female pattern of an increasing tendency for positive studies, which is consistent with different patterns of past smoking between sexes.
Factors Obscuring an Association Between Smoking and Colorectal Cancer
The failure to account for a lengthy induction period and for the intensity of smoking may account for most of the underestimation of the association between smoking and colorectal cancer. A positive association with colorectal cancer emerged only with the accrual of sufficient numbers of men and women who had begun smoking at least 40 years in the past. A relationship would have been most clearly observed only when an induction period and the intensity of smoking were taken into account, but even appropriate statistical analyses may not have been able to discern an association before 1965-1970 in men and before 1990 in women in the United States. •Does not include studies where only crude relaUve risks were provided. fRR = relative risk; M = male; F = female; CR = colorectal; cig/day = cigarettes/day, PY = pack-years; OR = odds ratio; CI = confidence interval.
Boutron et al., 1995 (France) (28)
Newcomb et al., 1995 (U.S.) (70) "Current" or "past" smoking or "total pack-years" of tobacco use are inconsistent indicators of smoking in the distant past. For example, in an analysis in the Nurses' Health Study on the basis of the 1976-1990 follow-up period, the proportion of total pack-years of cigarettes smoked more than four decades in the past accounted for less than 20% of the total. Therefore, the majority of pack-years of tobacco occurred in more recent years and was thus influenced by quantity rather than duration of smoking. Although clear associations emerged when smoking that occurred more than 40 years in the past was examined, total pack-years of smoking and current smoking were unrelated to the risk of colorectal cancer. In the Health Professionals FollowUp Study (26) , a positive association with current smoking was observed because current smoking correlated highly with smoking in the distant past among men. When controlled for longterm smoking, the association with current smoking did not Year of study exposure reflects the last year of follow-up for prospective studies and the last year of the study period for retrospective studies. When cigarette smoking was assessed in more than one way in an individual study, the relative risk reflects the following order of priority from highest to lowest: induction period assessment, age at initiation of smoking, years of smoking, pack-years, current smoking, and ever smoking. Year of study exposure reflects the last year of follow-up for prospective studies and the last year of the study period for retrospective studies. When cigarette smoking was assessed in more than one way in an individual study, the relative risk reflects the following order of priority: induction period assessment, age at initiation of smoking, years of smoking, pack-years, current smoking, and ever smoking.
persist, indicating that current smoking was acting as a surrogate of smoking in the distant past in the unadjusted analysis.
Other factors may have contributed to obscuring an association between smoking and cancer of the large bowel. Colorectal cancer may be diagnosed at a lower rate among tobacco users if smoking masks some of the gastrointestinal symptoms that lead to diagnosis. A lower detection rate of cancer among smokers is supported by the finding that smokers tend to be diagnosed with colorectal cancer at more advanced stages than nonsmokers (83) (84) (85) . In hospital-based, case-control studies, selection bias is of concern because smoking may be related to many conditions requiring hospitalization (86) ; thus, the use of hospitalized control subjects may overestimate smoking level in the source population.
A final note is that, even if the hypothesized association between tobacco and colorectal cancer is real, the same relationship may not be observed in all populations. For example, as described below, the frequency of some functional polymorphisms in xenobiotic metabolic enzymes that can activate or inactivate tobacco-related carcinogens varies profoundly across ethnic groups (87) . Thus, the susceptibility of different populations to tobacco can vary substantially. In addition, the prevalence of promoting factors or cofactors that influence the metabolism of genotoxic compounds (initiators) may vary across populations. For example, we estimated an approximate 40-year induction period in the United States, a population at high risk of colorectal cancer. In low-risk populations, presumably less exposed to promoting factors, the time interval from smoking to the heightened risk for colorectal cancer may be even longer.
Smoking and Secular Trends in Colorectal Cancer in the United States
At the beginning of this century, age-adjusted colorectal cancer incidence and mortality rates were slightly higher among women, and by 1950, rates in men and women were similar. Yet, by 1986, incidence rates were 34% higher and mortality rates were 44% higher in men. The rise in incidence has been limited to men aged 54 years or older (88) . A major reduction in colorectal cancer mortality occurred among women, while mortality rates among men remained relatively stable. Thus, because of a marked rise in incidence rates among men, improved survival (possibly due to treatment improvements and earlier diagnosis) was negated in the mortality rate. In contrast, among women, incidence rates were stable, or at least increasing at much lower rates, and improved survival resulted in lower mortality rates. The various factors that may influence incidence and mortality, including changing patterns of risk factors, improvements in detection, removal of precursor lesions, and improvement in treatment, are complex to separate, but nonetheless, the steadily increasing incidence rates among males relative to females in the latter half of this century suggest that the prevalence of one or more risk factors has increased in men.
This relatively unappreciated and unexplained epidemic limited to men is consistent with smoking patterns over this century, if a period of three to four decades between time of smoking and cancer risk is taken into account. That this increase has occurred primarily in men over the age of 54 years is consistent with the notion that few individuals under the age of 55 years would have accrued substantial pack-years of smoking more than 35-40 years in the past. In the Health Professionals and Nurses' Health Study cohorts, this age-related phenomenon was observed directly-the increased risk of colorectal cancer observed with smoking was limited to those aged 55 years and older and only among those who had begun smoking more than 35-40 years in the past (26, 27) . In Fig. 3 , we observe a close correspondence in time between the U.S. studies showing a positive association with smoking in men and the rising male/female mortality ratio for colorectal cancer. As studies began finding a positive association in men, which corresponded with cigarette consumption more than 40 years in the past (Fig.  2) , colorectal cancer mortality began rising in men relative to women. These patterns suggest that the epidemic of smoking among men in the United States earlier in the century may have contributed to their increasing burden of colorectal cancer.
Smoking-Related Carcinogens and Their Metabolism
An influence of smoking on risk for colorectal cancer would most likely be caused by carcinogens, including polynuclear retrospective study with population controls; { ) = retrospective study with hospital controls. Numbers in parentheses, brackets, and braces are reference numbers. Year of study exposure reflects the last year of follow-up for prospective studies and the last year of study period for retrospective studies. When cigarette smoking was assessed in more than one way in an individual study, the relative risk reflects the following order of priority from the highest to lowest: induction period assessment, age at initiation of smoking, years of smoking, pack-years, current smoking, and ever smoking.
aromatic hydrocarbons (PAHs), nitrosamines, and aromatic amines {89), formed during the burning of tobacco. These carcinogens could readily reach the mucosa of the large bowel through the circulatory system {90), or they could reach the large bowel through direct ingestion {64), as suggested by the higher risk for colorectal cancer among smokers of pipes or cigars (97) . Heterocyclic amines in cigarette smoke condensate, such as 2-amino-l-methyl-6-phenylimidazol [4,5-(3] pyridine (PhIP) {92), are reasonable candidates (95); results of in vitro studies and animal models suggest that they increase risk for colorectal cancer {94). Smoking is associated with DNA adducts {95,96) and with a higher risk for cancer {97) in various tissues, including the stomach, kidney, and pancreas, which are not in direct contact with tobacco smoke. If smoking-related carcinogens are involved in colorectal carcinogenesis, genetic polymorphisms in the various enzymes involved in metabolism of nitrosamines, aromatic amines, and PAHs are likely to influence the risk for this cancer. The metabolism of many of these compounds is mediated in part by cytochromes P450 1A1 (CYP1A1) and P450 1A2 (CYP1A2), which generate reactive metabolites that can produce DNA adducts. Enhanced metabolic activation of PAHs has recently been observed in homozygotes for a Msp I mutation in the 3'-end of CYP1A1. The polymorphism associated with enhanced activation of CYPlAl is related to higher risk for colorectal carcinoma in situ and cancer {98). A polymorphism has also been described that causes a highly inducible (by smoking, for example) state of CYP1A2 {99). This polymorphism probably resides in a gene controlling CYP1A2 expression or inducibility. Enhanced activation of CYP1A2 has been recently associated with higher risk of colorectal adenoma and cancer (700).
Acetylation polymorphisms resulting from different forms of the /V-acetyltransferase gene 2 (NAT-2) lead to either fast or slow acetylation of xenobiotics, including potential smoking-related carcinogens {99). If tobacco is an important source of colorectal carcinogens, rapid acetylators may be at higher risk for large-bowel cancer. Individuals with a combined rapid CYP1A2 and NAT-2 phenotype were at almost threefold elevated risk for colorectal adenoma and cancer {100). Results of two other studies {101, 102) show an excess of rapid acetylators in patients with colon cancer, although two others {103,104) did not. One of the null studies {104) was conducted in Japan, where cigarette smoking is a more recent phenomenon and few individuals were likely to have been smoking more than four decades in the past.
In contrast to enzymes that may activate carcinogens, glutathione S-transferase (GSTM1) detoxifies carcinogens, including smoking-related carcinogens formed by CYPlAl, and presumably would lower the risk of colorectal neoplasia. A genotype for GSTM1 (GSTMl-null), which is associated with inactivity of this enzyme, has been described in 40%-50% of the Caucasian population {105,106). One study {107) found that adenoma prevalence was 10-fold higher among fast-acetylating smokers with the GSTMl-null genotype, although the confidence intervals were wide because of small numbers. Moreover, the GSTMl-null genotype appears to be more frequent among patients with colorectal cancer, particularly among those with proximal cancers {108,109).
The accumulating, although incomplete, evidence that genetic polymorphisms in xenobiotic metabolic enzymes are related to colorectal neoplasia is consistent with an association between tobacco and risk for large-bowel cancer. The preliminary evidence that some of these polymorphisms are related to adenoma risk {107,100) suggests that extrinsic carcinogens are a source of initiators. Possibly, tobacco and other sources of carcinogens contribute to the carcinogenic load of the colorectum. Considering the interaction among diet, smoking, and genetic factors may help us to better understand the causes of colorectal cancer. Moreover, genetic variations among ethnic groups could contribute to some of the variability in results regarding smoking and colorectal cancer risk. For example, the population frequency of the GSTMl-null genotype varies from 10% to 100%, depending on the ethnic group {87). The described polymorphisms plus those in other enzymes (for example, NAT-1) may contribute to disparate susceptibilities to tobacco in diverse populations.
Smoking and Genetic Alterations of Colorectal Cancer
We have argued that an association between smoking and colorectal cancer hinges on the critical assumption that smoking causes a specific irreversible lesion that may lead to a cancer after an induction period lasting approximately 40 years. Considering this model within the context of the described genetic alterations may generate insights into the pathobiology and the natural history of colorectal cancer. The combined effects of mutational activation of oncogenes and the inactivation of tumor suppressor genes play a substantial role in colorectal tumor development {110). The series of genetic alterations involved in colorectal tumorigenesis identified thus far include, among others, the K-ras oncogene on the short arm of chromosome 12 and several tumor suppressor genes, including the APC gene on chromosome 5q and the p53 gene (also known as TP53) on chromosome 17q (//£>) • We propose that carcinogens from smoke may act as mutagenic agents of these or other important genes and consider the expected impact of mutations in these genes. In colorectal cancer, TP53 mutations occur late in the development of approximately half of cancers. We would expect mechanisms of p53 mutation in colorectal cancer to be unrelated to smoking because smoking is not a late-acting risk factor for this cancer. In addition, the mutational spectra of p53 in colorectal cancer suggests that "spontaneous" deamination at CpG sites is the predominant mechanism for the p53 mutations {111). To our knowledge, only one study {112) has investigated the association between p53 overexpression (a marker of p53 mutations) and cigarette smoking in colorectal cancer. In that study, smoking status or total pack-years of smoking was not associated with cases that were positive for p53 mutations, but current and past smokers had a twofold risk of developing cancers without p53 overexpression. These findings suggest that p53-mutated tumors are unrelated to smoking history.
Ras mutations have been found to be associated with heavy smoking in lung and oral cancers {113). Mutations of the ras proto-oncogene occur relatively early in approximately half of colorectal cancers, but usually occur after APC mutations {114). Ras mutations, relatively rare in small adenomas and common in large adenomas, fit the pattern of adenoma promotors better than the pattern of adenoma initiators.
APC mutations are observed in the smallest visible adenomas {12) and have been observed in microscopic dysplastic aberrant crypts, believed to be precursors of visible tumors {114). It is now believed that most sporadic cancers are initiated with a somatic APC mutation because mutations of the APC gene are commonly found in the smallest adenomas and because the frequency of the mutations remains constant from small adenomas to carcinomas {12). Although we are not aware of any study that has examined smoking in relation to APC mutations, two indirect observations suggest a connection between smoking and APC mutations. As discussed above, the time intervals from birth to the development of small adenomas, large adenomas, and cancers in patients with FAP, who have a germline APC mutation, are remarkably similar to the time intervals from initiation of smoking to the increased risk of these lesions in sporadic cases. A second observation consistent with the premise that smoking is associated with APC mutations is based on the mutational spectra of APC mutations in sporadic tumors. Generally, specific environmental exposures yield distinct mutations in tumor-suppressor genes and proto-oncogenes {115). The specific mutations in APC are heterogeneous among different tumors {12), which is consistent with diverse mutagenic mechanisms. Of note, a proportion of the mutations are consistent with those expected with tobacco-related mutagens (e.g., benzo[a]pyrene-induced G to T transversions) {116). While no direct proof links tobacco with these mutations, the observed mutational pattern is expected if smoking causes a part of, but not all, colorectal cancers.
It is quite plausible that specific tobacco-related carcinogens may have specific effects on some genes (e.g., APC) but not others (e.g., p53). In fact, within the same colorectal cancer, the nature of APC mutations is quite different from that of p53 mutations, suggesting a difference in the nature of environmental carcinogens contributing to APC and p53 mutations {38).
Public Health, Clinical, and Research Implications
The public health impact of a causal connection between tobacco and colorectal cancer would be important. In a study among U.S. male veterans {43), it was noted that if the association between cigarette smoking and colorectal cancer is causal, tobacco use may be responsible for 16% of the colon cancer deaths and 22% of the rectal cancer deaths. In the Health Professionals Follow-Up Study {26), 21% of the colorectal cancer cases were attributable to smoking. These estimates would imply that approximately 16 000 new cases and 6000 deaths from colorectal cancer in U.S. males are currently attributable to smoking. For women, the proportion of colorectal cancers attributable to smoking has not been appreciable to date, but may begin rising as the impact of women's smoking behavior in the 1950s and 1960s becomes manifest. Although the cessation of smoking at any age has important health benefits, the prevention of smoking among adolescents and young adults is necessary with regard to colorectal cancer prevention because the effect appears to be irreversible.
From a public health perspective, it is important to note that other modifiable risk factors may act in concert with tobacco. Although smoking may "initiate" cells, possibly by genotoxicity, promoting factors are likely to influence which initiated cells or clones are likely to progress. Thus, factors other than smoking may be important at later stages of colorectal carcinogenesis, including physical activity, body mass, alcohol consumption, use of anti-inflammatory drugs, and various dietary factors. The proposed mechanism that smoking causes irreversible genetic damage and that influences occurring later promote tumor growth is quite consistent with many animal models, for which an irreversible initiating event followed by continuing promotional influences is required for tumor development.
The fact that smoking has been a significant and consistent predictor of higher risk for adenoma, including large adenoma, may have clinical implications. Potential interventions, such as sigmoidoscopic screening or prophylactic use of aspirin, need to be evaluated according to their own merits, but final recommendations may need to account for smoking history. The strength of the association between smoking and large adenoma risk is at least as strong as that with family history, which is usually con-sidered for screening recommendations (117) , and the number of colorectal cancers attributable to smoking is greater than that attributed to family history in men. For example, in the Health Professionals Follow-Up Study, approximately 7% of the cases of colorectal cancer were attributable to a family history in a first-degree relative (118) , in contrast to about 21% attributable to tobacco. Family history may be associated with cancers at earlier age, whereas the impact of smoking increases with advancing age.
Future epidemiologic studies should account explicitly for induction periods when assessing the smoking-colorectal cancer association, rather than relying on indirect surrogates such as pack-years of smoking. Additional study of women is particularly warranted because the current data are more limited than that for men, and only relatively recently have there been sufficient numbers of women who began smoking more than 40 years ago. Studies correlating smoking history with specific mutational spectra in critical genes, such as APC, may provide useful information regarding the mechanism underlying the tobaccocolorectal neoplasm association. Differences in the genetic susceptibility to cigarette smoke should also be considered, particularly when interpreting disparate results from studies conducted in different populations.
Summary
The overall evidence along several different lines supports the hypothesis that smoking is an initiator of colorectal carcinogenesis. With the assumption that an increased risk emerges only about four decades after one begins smoking, a relatively consistent pattern materializes from apparently conflicting studies. The consistent finding of a positive association between smoking and the risk of incident and recurrent adenomas probably results from a presumably much shorter induction period for these lesions. Moreover, the adenoma studies were conducted relatively recently, ensuring that sufficient numbers of smokers had been long-term smokers. Studies of smoking and colorectal cancer have been more equivocal, but when the findings of these studies are plotted against the time when the studies were conducted (Figs. 1 and 2) , the relative risks correspond closely to the degree of smoking in the population that had occurred at least 40 years in the past. The diverging pattern of colorectal cancer incidence and mortality rates between men and women in the United States in this century, which has been unexplained, is consistent with the predicted effect of long-term smoking. The increasing male-to-female mortality ratio from colorectal cancer over time corresponds closely to when studies in males began to demonstrate an association with smoking, as shown in Fig. 3 .
Other evidence supports the requirement for a very long induction period for most colorectal cancers. Many potential carcinogens in tobacco smoke could reach the large bowel through the circulatory system. Some of the specific mutations in the APC gene, a tumor suppressor gene important early in colorectal carcinogenesis, are consistent with mutations induced by tobacco-related carcinogens. The emerging evidence that p°ly-morphisms in the metabolic enzymes GST, CYP450, and NAT-2, which are expected to enhance exposure to smoke-related carcinogens, are associated with higher risk for colorectal adenoma and cancer, particularly among smokers, is also consistent with a role of tobacco. We believe that this large and diverse body of evidence strongly supports the hypothesis that tobacco is an initiator of colorectal carcinogenesis. On the basis of this evidence, intensified effort to prevent smoking among young people is warranted.
